<DOC>
	<DOCNO>NCT00451139</DOCNO>
	<brief_summary>The purpose study evaluate potential side-effects artemether / lumefantrine antimalarial auditory function .</brief_summary>
	<brief_title>Ototoxicity Artemether / Lumefantrine ( Coartem ) Other Antimalarials</brief_title>
	<detailed_description>Artemisinin base combination therapy ( ACT ) currently promise treatment option uncomplicated falciparum malaria . There controversial report possible ototoxicity artemether / lumefantrine ( Coartem® ) retrospective study . In investigation treatment uncomplicated malaria artemether / lumefantrine , quinine , side-effects hear know , atovaquone / proguanil , effect report , compare . Auditoy function examine ( Auditory Brainstem Response , Pure-tone Audiometry , Otoacustic Emissions ) treatment , 7 , 28 , , determination irreversibility , 90 day .</detailed_description>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Proguanil</mesh_term>
	<mesh_term>Atovaquone</mesh_term>
	<mesh_term>Atovaquone , proguanil drug combination</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Quinine</mesh_term>
	<criteria>Patients age 5 year Uncomplicated falciparum malaria Axillary Temperature ≥37,5°C history fever within previous 24 hour Ability tolerate oral therapy Informed consent patient parent/guardian child Residence study area Known suspect hear deficit Adequate antimalarial treatment within previous 7 day Mixed infection Danger sign sign severe malaria define WHO Presence severe underlie disease ( cardiac , renal , hepatic disease , malnutrition , know HIV infection ) Concomitant disease mask assessment response History allergy intolerance study medication Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
</DOC>